Company intelligence / Profile preview

WestChina-Frontier PharmaTech

Chengdu, Sichuan, Chinacmocro.com ↗

Ownership: Private
Development stage: Other

Overview

WestChina‑Frontier PharmaTech is one of China's leading preclinical contract research organizations. It provides GLP/non‑GLP services in pharmacodynamics, toxicology, pharmacokinetics, and biological analysis to support global drug registration. The company has completed thousands of new drug evaluations with a high approval pass rate for both domestic and international submissions.

Modalities: Small moleculeBiologicVaccineCell therapyGene therapy
Industry: Contract Research Organization

Partnerships

Experimental Pathology Laboratories Inc. – strategic alliance for pathology peer review services to support regulatory submissions internationally

Beyond the preview

Go deeper on WestChina-Frontier PharmaTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WestChina-Frontier PharmaTech.

Explore the full profile